Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Dow
Covington
Chubb
Fuji
Moodys
Medtronic
Baxter
Chinese Patent Office

Generated: July 21, 2018

DrugPatentWatch Database Preview

Dextroamphetamine sulfate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for dextroamphetamine sulfate and what is the scope of dextroamphetamine sulfate patent protection?

Dextroamphetamine sulfate
is the generic ingredient in five branded drugs marketed by Impax Labs Inc, Able, Actavis Elizabeth, Mayne Pharma, Mylan Pharms Inc, Nesher Pharms, Specgx Llc, Vintage Pharms, Teva, Glaxosmithkline, Outlook Pharms, Tris Pharma Inc, Ani Pharms Inc, Arbor Pharms Llc, Aurolife Pharma Llc, Avanthi Inc, Barr, Epic Pharma Llc, Halsey, Lannett, Mast Mm, Novel Labs Inc, Purepac Pharm, Sandoz, Sunrise Pharm Inc, Vintage Pharms Llc, Vitarine, Shire, and Ferndale Labs, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for dextroamphetamine sulfate. Twenty-six suppliers are listed for this compound.
Summary for dextroamphetamine sulfate
Pharmacology for dextroamphetamine sulfate
Medical Subject Heading (MeSH) Categories for dextroamphetamine sulfate

US Patents and Regulatory Information for dextroamphetamine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 090533-002 Oct 25, 2011 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs Inc DEXEDRINE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 017078-002 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Nesher Pharms DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 209111-003 Jun 27, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sunrise Pharm Inc DEXTROAMPHETAMINE SULFATE dextroamphetamine sulfate TABLET;ORAL 210059-002 Oct 18, 2017 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Accenture
Deloitte
Cipla
Farmers Insurance
Covington
Moodys
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.